Literature DB >> 17977276

Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation.

Changbin Shi1, Robert Shenkar, H Hunt Batjer, Irene J Check, Issam A Awad.   

Abstract

OBJECT: Mechanisms of cerebral cavernous malformation (CCM) pathogenesis include genetic predisposition in some cases, but other factors are likely to be involved in lesion proliferation and clinical manifestations. Given the unique antigenic milieu of CCMs, there may be a characteristic immune response in these lesions. We hypothesize that the immunoglobulin (Ig) fraction in CCMs reflects an oligoclonal immune response not present in paired sera from the same patients or in other types of cerebrovascular malformations.
METHODS: Surgically excised lesions from five patients with CCMs, three patients with arteriovenous malformations (AVMs), and four normal brain control specimens obtained at autopsy were homogenized and extract tested for IgG clonality by isoelectric focusing in parallel with each patient's serum.
RESULTS: The authors detected B cells in all three lesions examined, and plasmacytes in two out of three lesions examined. Four of five extracts of homogenized CCMs showed an oligoclonal pattern of IgG distinct from the polyclonal pattern seen in those patients' sera. Immununoglobulin G oligoclonality was not seen in AVMs or control brain specimens.
CONCLUSIONS: The results of isoelectric focusing studies showed that CCM lesions had oligoclonal patterns of IgG unrelated to peripheral blood contamination, indicating selective synthesis of IgG within the lesions. This finding probably reflects a clonal expansion of B cells and/or plasmacytes in CCMs, an event that might be antigen-driven or a potential marker of inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977276     DOI: 10.3171/JNS-07/11/1023

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

1.  Pilocytic astrocytoma of the spinal cord in an adult.

Authors:  Ali Saad; Sagun Tuli; Eman N Ali; Maria Houtchens; Ivana Delalle; Santosh Kesari
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

Review 2.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

Review 3.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

4.  Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.

Authors:  Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su
Journal:  Neuroimmunol Neuroinflamm       Date:  2014

5.  B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.

Authors:  Changbin Shi; Robert Shenkar; Hussein A Zeineddine; Romuald Girard; Maged D Fam; Cecilia Austin; Thomas Moore; Rhonda Lightle; Lingjiao Zhang; Meijing Wu; Ying Cao; Murat Gunel; Angeliki Louvi; Autumn Rorrer; Carol Gallione; Douglas A Marchuk; Issam A Awad
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-16       Impact factor: 4.147

Review 6.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

7.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

8.  Immune response in human cerebral cavernous malformations.

Authors:  Changbin Shi; Robert Shenkar; Hongyan Du; Edward Duckworth; Harish Raja; H Hunt Batjer; Issam A Awad
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 9.  Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.

Authors:  Aubrey C Chan; Dean Y Li; Michel J Berg; Kevin J Whitehead
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.